Drug: SOLIRIS Injury: Thrombotic microangiopathy Quarter: 2016Q3
Total Records: 26 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127077481 | SOLIRIS | Thrombotic microangiopathy | ALEXION | 0.00 | F | 0 | 20160901 | US |
127117011 | SOLIRIS | Thrombotic microangiopathy | ALEXION | 0.00 | M | 0 | 20160902 | US |
127194271 | SOLIRIS | Thrombotic microangiopathy | ALEXION | 0.00 | M | 0 | 20160907 | US |
127209981 | SOLIRIS | Thrombotic microangiopathy | ALEXION | 58.00 YR | F | 0 | 20160907 | GB |
127756311 | SOLIRIS | Thrombotic microangiopathy | ALEXION | 6.00 YR | M | 19 KG | 20160923 | GB |
127868771 | SOLIRIS | Thrombotic microangiopathy | ALEXION | 26.00 YR | M | 0 | 20160927 | GB |
Total Records: 26 Number of Pages: 2